Study Design and Baseline Characteristics in Phase 2 Studies of Elezanumab, a Potential Neurorestorative Therapy for Multiple SclerosisBruce Cree,Adam Ziemann,Kimberly Pfleeger,Brittany Schwefel,Annette Wundes,Mark FreedmanNEUROLOGY(2021)引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要